Your doctor will monitor your heart function closely before and during your treatment with Herceptin SC. Your heart function may also be monitored for years after ceasing Herceptin SC treatment.

They detail how current therapeutic antibodies can be modified to increase their specificity and decrease potential adverse reactions, for example by modulating their immune effector functions ...

The maker of breast cancer drug Herceptin has applied for a licence for it to be used to treat the early stages of the disease. Manufacturer Roche claims its research shows the drug halves the risk of ...

While the pembrolizumab copy was eye-catching, the firm’s next big biosimilar launch in Europe is a version of Roche’s Herceptin (trastuzumab). Biosimilar companies are poised to launch ...

Mundipharma has signed a deal with Celltrion to market a biosimilar of Roche’s Herceptin (trastuzumab) in seven European countries. Breast cancer blockbuster Herceptin earned $2.26 billion in ...